Arcturus Therapeutics Holdings Inc.
A San Diego-based company that makes messenger RNA (mRNA) medicines and vaccines, including a COVID-19 vaccine and experimental treatments for rare diseases. Founded in 2013 by two scientists, it is named after Arcturus, the brightest star in the constellation Boötes, whose Greek name means "Guardian of the Bear." Its delivery platform, called LUNAR, is designed to carry RNA molecules safely into human cells.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| ARK Investment Management LLC | 13G/APassive | 10.37% | 2.95M | May 7, 2026 |
| Catherine D. Wood | 13G/APassive | 10.37% | 2.95M | May 7, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 26, 2026 |
| Balyasny Asset Management L.P. | 13G/APassive | 0% | 0 | Feb 17, 2026 |
| BAM GP LLC | 13G/APassive | 0% | 0 | Feb 17, 2026 |
| Balyasny Asset Management Holdings LP | 13G/APassive | 0% | 0 | Feb 17, 2026 |
| Dames GP LLC | 13G/APassive | 0% | 0 | Feb 17, 2026 |
| Dmitry Balyasny | 13G/APassive | 0% | 0 | Feb 17, 2026 |
| Federated Hermes, Inc. | 13G/APassive | 11.63% | 3.30M | Jan 8, 2026 |
| Voting Shares Irrevocable Trust | 13G/APassive | 11.63% | 3.30M | Jan 8, 2026 |